* Cisco down in premarket after results, outlook
* Jobless claims rose more than expected in latest week
* Amgen shares fall in premarket after drug trial
* Dow down 2 pts, S&P down 0.5 pt, Nasdaq up 1.25 pt
(Updates prices, adds economic data and Putin comments)
By Ryan Vlastelica
NEW YORK, Aug 14 U.S. stock index futures
pointed to a flat open on Thursday as investors found few
reasons to buy following a sharp rally in the previous session
and amid signs of weakness in Europe and ongoing uncertainty
* Trading is likely to continue being driven by overseas
issues, with the latest data out of Europe showing the euro
zone's economy ground to a halt in the second quarter.
* Russian President Vladimir Putin said his country would
stand up for itself but not at the cost of confrontation with
the outside world, a conciliatory note after months of tough
rhetoric over the crisis in Ukraine.
* In the latest U.S. data, jobless claims rose more than
expected in the latest week, though the long-term trend was
still viewed as positive. The claims data comes a day after
retail sales report also pointed to waning economic momentum,
though tepid data could give the Federal Reserve more support to
move slowly on raising interest rates, a situation that favors
* Wal-Mart Stores Inc reported flat same-store sales
for the second-quarter and cut its full-year profit outlook.
Shares of the Dow component fell 0.6 percent to $73.60 before
* Cisco Systems Inc fell 1.2 percent to $24.90 in
premarket trading. The Dow component gave a tepid outlook a day
earlier for its current quarter and announced massive job cuts
even as revenue beat expectations.
* Wal-Mart and Cisco are the latest major names to issue
cautious outlooks. On Wednesday, Macy's Inc cut its
full-year same-store sales outlook while Deere & Co cut
its profit view.
* S&P 500 e-mini futures fell 0.5 point but remained
above fair value, a formula that evaluates pricing by taking
into account interest rates, dividends and time to expiration on
the contract. Dow Jones industrial average e-mini futures
fell 2 points and Nasdaq 100 e-mini futures rose
* Wall Street rallied on Wednesday, with the Dow Jones
industrial average returning to positive territory for the year.
The S&P 500 is about 2.1 percent below a late-July record close.
* Amgen Inc fell 2.5 percent to $124.21 in
premarket trading after a drug failed to extend survival
compared to standard care in a trial involving patients with
advanced multiple myeloma.
* The chief executive of NewLink Genetics Corp,
which licensed an Ebola vaccine developed by Canadian government
scientists, late Wednesday told Reuters it has enough doses on
hand to launch the first human safety trial of an Ebola vaccine
* The U.S. Food and Drug Administration late Wednesday said
it had approved a new Merck & Co insomnia drug, sending
shares up 1.7 percent to $58.86 before the bell.
(Editing by Bernadette Baum and Nick Zieminski)